Correlation Between Nabriva Therapeutics and CTi Biopharma
Can any of the company-specific risk be diversified away by investing in both Nabriva Therapeutics and CTi Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nabriva Therapeutics and CTi Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nabriva Therapeutics AG and CTi Biopharma Corp, you can compare the effects of market volatilities on Nabriva Therapeutics and CTi Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nabriva Therapeutics with a short position of CTi Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nabriva Therapeutics and CTi Biopharma.
Diversification Opportunities for Nabriva Therapeutics and CTi Biopharma
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Nabriva and CTi is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Nabriva Therapeutics AG and CTi Biopharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTi Biopharma Corp and Nabriva Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nabriva Therapeutics AG are associated (or correlated) with CTi Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTi Biopharma Corp has no effect on the direction of Nabriva Therapeutics i.e., Nabriva Therapeutics and CTi Biopharma go up and down completely randomly.
Pair Corralation between Nabriva Therapeutics and CTi Biopharma
If you would invest 909.00 in CTi Biopharma Corp on August 25, 2024 and sell it today you would earn a total of 0.00 from holding CTi Biopharma Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nabriva Therapeutics AG vs. CTi Biopharma Corp
Performance |
| Timeline |
| Nabriva Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| CTi Biopharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nabriva Therapeutics and CTi Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nabriva Therapeutics and CTi Biopharma
The main advantage of trading using opposite Nabriva Therapeutics and CTi Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nabriva Therapeutics position performs unexpectedly, CTi Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTi Biopharma will offset losses from the drop in CTi Biopharma's long position.The idea behind Nabriva Therapeutics AG and CTi Biopharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| CTi Biopharma vs. Rigel Pharmaceuticals | CTi Biopharma vs. Fortress Biotech | CTi Biopharma vs. Reviva Pharmaceuticals Holdings | CTi Biopharma vs. Protalix Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |